VLTS-934

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameVLTS-934
Drug Alias NamePoloxamerPINC polymerperipheral arterial disease therapyVLTS-934
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUrigen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValentis
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A